Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2526)
  3. Review (121)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5696)
  2. Department of Medicine (5686)
  3. GSK Faculty (1659)
  4. Human Oncology and Pathogenesis Program (1158)
  5. Department of Pathology and Laboratory Medicine (1130)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (786)
  4. Dean Bajorin (664)
  5. Michael Morris (588)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (204)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (690)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (304)

More Publishers

Results (5696)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of crossover and baseline prognostic factors on overall survival (OS) with abiraterone acetate (AA) in the COU-AA-302 final analysis
    Meeting Abstract

    Ryan, C. J.; Smith, M. R.; Fizazi, K.; Saad, F.; Sternberg, C. N.; Logothetis, C.; Small, E. J.; Carles, J.; Flaig, T. W.; Taplin, M. E.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Impact of chemotherapy (CTX) on venous thromboembolism (VTE) and prognostic implications in patients with metastatic urinary tract tumors (UTT)
    Meeting Abstract

    Ramos, J.; Casey, M. F.; Crabb, S. J.; Bamias, A.; Harshman, L. C.; Wong, Y. N.; Bellmunt, J.; De Giorgi, U.; Ladoire, S.; Powles, T.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Radical prostatectomy as a component of multimodal therapy for highly selected M1 prostate cancer patients
    Meeting Abstract

    O'Shaughnessy, M.; Eastham, J. A.; Bochner, B. H.; Laudone, V. P.; Carver, B. S.; Sjoberg, D.; Scardino, P. T.; Scher, H. I.; Touijer, K. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Effect of radium-223 dichloride (Ra-223) on pain from US EAP
    Meeting Abstract

    Morris, M. J.; Sartor, A. O.; Vogelzang, N. J.; Shore, N. D.; Cislo, P.; Bangerter, K.; Sweeney, C.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Pathologic correlation of (89)Zr-Df-IAB2M antiprostate-specific membrane antigen (PSMA) minibody in patients with metastatic prostate cancer
    Meeting Abstract

    Morris, M. J.; Solomon, S. B.; Durack, J. C.; O'Donoghue, J. A.; Lyashchenko, S. K.; Ruan, S. T.; Carrasquillo, J. A.; Lewis, J. S.; Martinez, D. F.; Parada, N. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Effects of radium-223 dichloride (Ra-223) with docetaxel (D) versus D on prostate-specific antigen (PSA) and bone alkaline phosphatase (bALP) in patients (pts) with castration-resistant prostate cancer (CRPC) and bone metastases (mets): A phase 1/2a clinical trial
    Meeting Abstract

    Morris, M. J.; Higano, C. S.; Scher, H. I.; Sweeney, C.; Antonarakis, E. S.; Shevrin, D. H.; Ryan, C. J.; Lorlot, Y.; Fizazi, K.; Pandit-Taskar, N.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Bevacizumab monotherapy as salvage therapy for patients with advanced clear cell renal cell carcinoma pretreated with targeted drugs
    Meeting Abstract

    Lee, C. H.; Hoetker, A. M.; Voss, M. H.; Feldman, D. R.; Woo, K.; Patil, S.; Coskey, D. T.; Akin, O.; Hsieh, J.; Motzer, R. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Proteomic stratification of clear cell renal cell carcinoma utilizing The Cancer Genome Atlas (TCGA) with external validation
    Meeting Abstract

    Kaffenberger, S. D.; Ciriello, G.; Winer, A. G.; Voss, M. H.; Maranchie, J. K.; Tamboli, P.; Rathmell, K.; Choueiri, T. K.; Motzer, R. J.; Coleman, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Comparison of genetic alterations from the bladder cancer genome atlas (TCGA) and a prospective set of high-grade urothelial carcinoma tumors using a CLIA laboratory next generation sequencing assay
    Meeting Abstract

    Iyer, G.; Bagrodia, A.; Cha, E. K.; Boyd, M. E.; Zehir, A.; Cheng, D. T.; Hyman, D. M.; Bambury, R. M.; Arcila, M. E.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase 2 study of the pan-isoform PI3 kinase inhibitor BKM120 in metastatic urothelial carcinoma patients
    Meeting Abstract

    Iyer, G.; Tully, C. M.; Garcia-Grossman, I. R.; Scott, S. N.; Boyd, M. E.; McCoy, A. S.; Berger, M. F.; Al-Ahmadie, H.; Solit, D. B.; Rosenberg, J. E.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save